Decellularized Dermis Bio Implants for Soft Tissue Repair

This announcement serves as a Sources Sought Synopsis issued for the purpose of market research in accordance with Federal Acquisition Regulation (FAR) Part 10 for an upcoming acquisition at the United States Air Force Academy (USAFA). This sources sought is issued solely for information and planning purposes and does not constitute a solicitation. DO NOT submit a quote or proposal in response to this synopsis. For the purpose of this acquisition, the North American Industry Classification System Code (NAICS) is 325414 Biological Product Manufacturing and the size standard in number of employees is 1,250. The purpose of this notice is to identify businesses capable of providing two (2) Decellularized Dermis Bio Implants for Soft Tissue Repair for the 10th Medical Group located at the United States Air Force Academy Ambulatory Surgical Center. All businesses that are capable of providing the Decellularized Dermis Bio Implant requirement as specified below are invited to respond. Interested small business vendors must reference their 8(a), HUB Zone, Women-owned, or Service Disabled Veteran status, if applicable. This must be signed by a company officer with authority to bind the company. Description of Requirement: Decellularized Dermis Bio Implants for Soft Tissue Repair Quantity: Two (2) Size: 3 mm thickness X 40 mm X 70 MM - Shall have accreditation form the American Association of Tissue Banks (AATB). - Shall be Food and Drug Administration (FDA) approved. Delivery: FOB Destination Attn: Surgical Support, Ambulatory Surgical Center 4102 Pinion Dr. USAF Academy, Colorado Springs, CO 80840 The proposed contract is anticipated to be a Firm-Fixed Price contract. All potential offerors are reminded, in accordance with FAR 52.212-4(t)(4), System for Award Management, lack of registration in the System for Award Management (SAM) will make an offeror ineligible for contract award. Offerors and Contractors may obtain information on registration and annual confirmation requirements via SAM accessed through http://www.sam.gov. Any information provided by industry to the Government as a result of this sources sought synopsis is voluntary. The Government will not pay for any information submitted in response to this sources sought synopsis. Any information provided by industry to the Government as a result of this sources sought synopsis is voluntary and the Government does not intend to pay for any information provided under this synopsis. Written responses will not be returned. If your are not interested in supplying this service, no response is necessary. If you are a potential source interested in participating in this procurement, please submit a written response with your capability statement on letterhead. Responses should also include the following: 1. If available, no more than three (3) past performance references with a point of contact, contract number, and telephone number. 2. Company name, mailing address, cage code, DUNS number, point of contact, telephone number and email address. 3. Business size status, e.g., 8(a), HUBZone, Woman Owned Small Business, Veteran-Owned or Service Disabled Veteran-Owned Small Business, large business, etc. 4. Appropriate written information and/or data supporting your capability to provide this product. This notice is designed to locate responsible sources that have an interest, and have the ability to provide the Decellularized Dermis Bio Implant requirement as specified above. If your organization is capable and qualified to provide these services, send the required response in writing to both the primary and alternate point of contact indicated within this announcement. Responses are due no later than 3 July 2017, 4:00 p.m. MDT. Responses should be addressed to the primary contact, Pamela Reimers, Contracting Specialist, 719-333-4493 or pamela.reimers@us.af.mil or the alternate point of contact, Chad Miller, Contracting Officer, 719-333-3829 or chad.miller.24@us.af.mil. AFFARS 5352.201-9101 OMBUDSMAN (JUN 2016) (a) An ombudsman has been appointed to hear and facilitate the resolution of concerns from offerors, potential offerors, and others for this acquisition. When requested, the ombudsman will maintain strict confidentiality as to the source of the concern. The existence of the ombudsman does not affect the authority of the program manager, contracting officer, or source selection official. Further, the ombudsman does not participate in the evaluation of proposals, the source selection process, or the adjudication of protests or formal contract disputes. The ombudsman may refer the interested party to another official who can resolve the concern. (b) Before consulting with an ombudsman, interested parties must first address their concerns, issues, disagreements, and/or recommendations to the contracting officer for resolution. Consulting an ombudsman does not alter or postpone the timelines for any other processes (e.g., agency level bid protests, GAO bid protests, requests for debriefings, employee-employer actions, contests of OMB Circular A-76 competition performance decisions). (c) If resolution cannot be made by the contracting officer, the interested party may contact the Center/MAJCOM/DRU or AFISRA ombudsmen, James Anderson 8110 Industrial Drive, Ste 103 USAFA, CO 80840 Telephone number 719-333-2074 FAX 719-333-9018 email: james.anderson@us.af.mil Concerns, issues, disagreements, and recommendations that cannot be resolved at the Center/MAJCOM/DRU or AFISRA level, may be brought by the interested party for further consideration to the Air Force ombudsman, Associate Deputy Assistant Secretary (ADAS) (Contracting), SAF/AQC, 1060 Air Force Pentagon, Washington DC 20330-1060, phone number (571) 256-2397, facsimile number (571) 256-2431. (d) The ombudsman has no authority to render a decision that binds the agency. (e) Do not contact the ombudsman to request copies of the solicitation, verify offer due date, or clarify technical requirements. Such inquiries shall be directed to the Contracting Officer. (End of clause)